Genky DrugStores Crecimiento futuro
Future controles de criterios 2/6
Genky DrugStores is forecast to grow earnings and revenue by 8.6% and 8.3% per annum respectively. EPS is expected to grow by 8.6% per annum. Return on equity is forecast to be 13.3% in 3 years.
Información clave
8.6%
Tasa de crecimiento de los beneficios
8.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Consumer Retailing | 12.8% |
| Tasa de crecimiento de los ingresos | 8.3% |
| Rentabilidad financiera futura | 13.3% |
| Cobertura de analistas | Low |
| Última actualización | 28 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets
Oct 30
Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600
Apr 27Recent updates
Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets
Oct 30What Genky DrugStores Co., Ltd.'s (TSE:9267) 28% Share Price Gain Is Not Telling You
Aug 07Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600
Apr 27Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing
Mar 07Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2027 | 240,850 | 8,610 | -52 | N/A | 2 |
| 6/30/2026 | 221,700 | 7,851 | -91 | N/A | 2 |
| 6/30/2025 | 203,900 | 7,210 | -818 | N/A | 2 |
| 9/20/2024 | 188,039 | 6,464 | N/A | N/A | N/A |
| 6/20/2024 | 184,860 | 6,324 | 2,815 | 13,256 | N/A |
| 3/20/2024 | 181,441 | 5,907 | N/A | N/A | N/A |
| 12/20/2023 | 177,152 | 5,580 | -1,512 | 10,740 | N/A |
| 9/20/2023 | 173,317 | 5,106 | N/A | N/A | N/A |
| 6/20/2023 | 169,059 | 4,764 | -1,155 | 8,773 | N/A |
| 3/20/2023 | 165,078 | 4,668 | N/A | N/A | N/A |
| 12/20/2022 | 162,272 | 4,559 | -1,123 | 9,177 | N/A |
| 9/20/2022 | 158,134 | 4,290 | N/A | N/A | N/A |
| 6/20/2022 | 154,639 | 4,420 | -4,431 | 6,076 | N/A |
| 3/20/2022 | 152,692 | 4,484 | N/A | N/A | N/A |
| 12/20/2021 | 149,500 | 4,527 | -240 | 8,809 | N/A |
| 9/20/2021 | 146,419 | 4,775 | N/A | N/A | N/A |
| 6/20/2021 | 142,376 | 4,831 | 3,121 | 12,075 | N/A |
| 3/20/2021 | 140,851 | 4,449 | N/A | N/A | N/A |
| 12/20/2020 | 136,390 | 4,455 | 2,338 | 11,396 | N/A |
| 9/20/2020 | 130,173 | 3,565 | N/A | N/A | N/A |
| 6/20/2020 | 123,603 | 2,755 | -3,594 | 7,411 | N/A |
| 3/20/2020 | 113,707 | 2,268 | N/A | N/A | N/A |
| 12/20/2019 | 108,305 | 1,958 | -7,861 | 2,946 | N/A |
| 9/20/2019 | 105,832 | 2,334 | N/A | N/A | N/A |
| 6/20/2019 | 103,897 | 2,697 | -6,422 | 4,300 | N/A |
| 3/20/2019 | 101,948 | 3,275 | N/A | N/A | N/A |
| 12/20/2018 | 100,167 | 3,179 | -3,257 | 4,694 | N/A |
| 9/20/2018 | 97,753 | 3,178 | N/A | N/A | N/A |
| 6/20/2018 | 94,869 | 3,118 | N/A | 5,365 | N/A |
| 3/20/2018 | 92,031 | 2,972 | N/A | N/A | N/A |
| 12/20/2017 | 89,301 | 2,880 | N/A | 6,866 | N/A |
| 9/20/2017 | 86,379 | 2,867 | N/A | N/A | N/A |
| 6/20/2017 | 83,399 | 2,845 | N/A | 5,238 | N/A |
| 3/20/2017 | 80,879 | 2,603 | N/A | N/A | N/A |
| 12/20/2016 | 78,640 | 2,462 | N/A | 2,805 | N/A |
| 9/20/2016 | 76,170 | 2,223 | N/A | N/A | N/A |
| 6/20/2016 | 73,495 | 1,901 | N/A | 2,695 | N/A |
| 3/20/2016 | 70,426 | 1,643 | N/A | N/A | N/A |
| 12/20/2015 | 67,761 | 1,740 | N/A | 3,498 | N/A |
| 9/20/2015 | 65,413 | 1,743 | N/A | N/A | N/A |
| 6/20/2015 | 63,143 | 1,761 | N/A | 4,758 | N/A |
| 3/20/2015 | 61,524 | 1,819 | N/A | N/A | N/A |
| 12/20/2014 | 60,811 | 1,635 | N/A | 3,767 | N/A |
| 9/20/2014 | 59,853 | 1,452 | N/A | N/A | N/A |
| 6/20/2014 | 57,949 | 1,171 | N/A | 3,662 | N/A |
| 3/20/2014 | 56,365 | 944 | N/A | N/A | N/A |
| 12/20/2013 | 54,710 | 768 | N/A | 3,446 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 9267's forecast earnings growth (8.6% per year) is above the savings rate (0.3%).
Beneficios vs. Mercado: 9267's earnings (8.6% per year) are forecast to grow slower than the JP market (8.9% per year).
Beneficios de alto crecimiento: 9267's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: 9267's revenue (8.3% per year) is forecast to grow faster than the JP market (4.2% per year).
Ingresos de alto crecimiento: 9267's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: 9267's Return on Equity is forecast to be low in 3 years time (13.3%).